Albion Financial Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.81M | Buy |
11,083
+644
| +6% | +$150K | 0.16% | 75 |
|
|
2026
Q1 | $2.55M | Buy |
10,439
+1,108
| +12% | +$258K | 0.16% | 74 |
|
|
2025
Q4 | $1.93M | Buy |
9,331
+23
| +0.2% | +$4.55K | 0.12% | 83 |
|
|
2025
Q3 | $1.73M | Buy |
9,308
+484
| +5% | +$82.9K | 0.1% | 85 |
|
|
2025
Q2 | $1.35M | Sell |
8,824
-200
| -2% | -$30.7K | 0.09% | 96 |
|
|
2025
Q1 | $1.5M | Buy |
9,024
+27
| +0.3% | +$4.22K | 0.11% | 97 |
|
|
2024
Q4 | $1.3M | Sell |
8,997
-200
| -2% | -$31K | 0.09% | 105 |
|
|
2024
Q3 | $1.49M | Buy |
9,197
+420
| +5% | +$66.9K | 0.1% | 96 |
|
|
2024
Q2 | $1.28M | Hold |
8,777
| – | – | 0.1% | 99 |
|
|
2024
Q1 | $1.39M | Hold |
8,777
| – | – | 0.11% | 91 |
|
|
2023
Q4 | $1.38M | Sell |
8,777
-179
| -2% | -$27.4K | 0.11% | 91 |
|
|
2023
Q3 | $1.39M | Sell |
8,956
-140
| -2% | -$23.1K | 0.13% | 86 |
|
|
2023
Q2 | $1.51M | Hold |
9,096
| – | – | 0.13% | 85 |
|
|
2023
Q1 | $1.41M | Sell |
9,096
-150
| -2% | -$24.2K | 0.13% | 89 |
|
|
2022
Q4 | $1.63M | Sell |
9,246
-254
| -3% | -$43.9K | 0.16% | 82 |
|
|
2022
Q3 | $1.55M | Hold |
9,500
| – | – | 0.16% | 83 |
|
|
2022
Q2 | $1.69M | Sell |
9,500
-74
| -0.8% | -$13.2K | 0.17% | 85 |
|
|
2022
Q1 | $1.7M | Sell |
9,574
-173
| -2% | -$29.4K | 0.14% | 90 |
|
|
2021
Q4 | $1.67M | Sell |
9,747
-3,091
| -24% | -$506K | 0.13% | 93 |
|
|
2021
Q3 | $2.07M | Sell |
12,838
-181
| -1% | -$30.9K | 0.18% | 86 |
|
|
2021
Q2 | $2.15M | Buy |
+13,019
| New | +$2.16M | 0.19% | 84 |
|
|
2020
Q4 | $1.83M | Buy |
11,613
+560
| +5% | +$82.6K | 0.18% | 81 |
|
|
2020
Q3 | $1.65M | Sell |
11,053
-495
| -4% | -$73.2K | 0.18% | 76 |
|
|
2020
Q2 | $1.62M | Sell |
11,548
-109
| -0.9% | -$15.9K | 0.19% | 74 |
|
|
2020
Q1 | $1.53M | Buy |
11,657
+115
| +1% | +$16.3K | 0.22% | 67 |
|
|
2019
Q4 | $1.68M | Buy |
11,542
+248
| +2% | +$33.6K | 0.2% | 78 |
|
|
2019
Q3 | $1.46M | Sell |
11,294
-676
| -6% | -$89.1K | 0.19% | 79 |
|
|
2019
Q2 | $1.67M | Buy |
11,970
+703
| +6% | +$97.3K | 0.22% | 74 |
|
|
2019
Q1 | $1.57M | Sell |
11,267
-95
| -0.8% | -$12.7K | 0.21% | 79 |
|
|
2018
Q4 | $1.47M | Sell |
11,362
-16,027
| -59% | -$2.24M | 0.23% | 75 |
|
|
2018
Q3 | $3.78M | Sell |
27,389
-139
| -0.5% | -$18.5K | 0.51% | 46 |
|
|
2018
Q2 | $3.34M | Buy |
27,528
+630
| +2% | +$78.6K | 0.48% | 46 |
|
|
2018
Q1 | $3.45M | Buy |
26,898
+33
| +0.1% | +$4.46K | 0.53% | 42 |
|
|
2017
Q4 | $3.75M | Sell |
26,865
-807
| -3% | -$112K | 0.57% | 41 |
|
|
2017
Q3 | $3.6M | Buy |
27,672
+5,928
| +27% | +$786K | 0.55% | 43 |
|
|
2017
Q2 | $2.88M | Sell |
21,744
-1,058
| -5% | -$135K | 0.48% | 44 |
|
|
2017
Q1 | $2.84M | Buy |
22,802
+3,542
| +18% | +$423K | 0.43% | 45 |
|
|
2016
Q4 | $2.22M | Sell |
19,260
-36,819
| -66% | -$4.25M | 0.37% | 49 |
|
|
2016
Q3 | $6.63M | Buy |
56,079
+40,113
| +251% | +$4.87M | 1.13% | 26 |
|
|
2016
Q2 | $1.94M | Buy |
15,966
+2
| +0% | +$227 | 0.35% | 42 |
|
|
2016
Q1 | $1.73M | Buy |
15,964
+90
| +0.6% | +$9.32K | 0.29% | 44 |
|
|
2015
Q4 | $1.63M | Sell |
15,874
-83
| -0.5% | -$8.35K | 0.28% | 47 |
|
|
2015
Q3 | $1.49M | Buy |
15,957
+137
| +0.9% | +$13.3K | 0.27% | 49 |
|
|
2015
Q2 | $1.54M | Sell |
15,820
-191
| -1% | -$19.1K | 0.26% | 50 |
|
|
2015
Q1 | $1.61M | Buy |
16,011
+175
| +1% | +$17.8K | 0.27% | 47 |
|
|
2014
Q4 | $1.66M | Sell |
15,836
-2,364
| -13% | -$249K | 0.29% | 47 |
|
|
2014
Q3 | $1.94M | Buy |
18,200
+215
| +1% | +$22.3K | 0.34% | 42 |
|
|
2014
Q2 | $1.88M | Buy |
17,985
+1
| +0% | +$101 | 0.33% | 49 |
|
|
2014
Q1 | $1.77M | Buy |
17,984
+1,653
| +10% | +$153K | 0.33% | 50 |
|
|
2013
Q4 | $1.5M | Buy |
16,331
+3,019
| +23% | +$278K | 0.28% | 51 |
|
|
2013
Q3 | $1.15M | Hold |
13,312
| – | – | 0.25% | 60 |
|
|
2013
Q2 | $1.14M | Buy |
+13,312
| New | +$1.13M | 0.25% | 57 |
|
Other funds holding JNJ
Albion Financial Group's JNJ Position: Q2 2026 in Review
Albion Financial Group increased its Johnson & Johnson (JNJ) stake by 6.2% in Q2 2026, buying an estimated $150K and bringing the position to 11,083 shares worth $2.81M. The position accounts for 0.16% of the portfolio, ranked #75.
Albion Financial Group first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.63M in Q3 2016. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Albion Financial Group held 11,083 shares of Johnson & Johnson worth $2.81M as of Q2 2026.
- Albion Financial Group bought 644 Johnson & Johnson shares in Q2 2026, an estimated $150K.
- Johnson & Johnson made up 0.16% of Albion Financial Group's portfolio in Q2 2026, its #75 holding.
- Albion Financial Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- Albion Financial Group's Johnson & Johnson position peaked at $6.63M in Q3 2016.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.